BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 19072886)

  • 1. Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents.
    Mally A; Dekant W
    Mol Nutr Food Res; 2009 Apr; 53(4):467-78. PubMed ID: 19072886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity.
    Adler M; Müller K; Rached E; Dekant W; Mally A
    Carcinogenesis; 2009 Apr; 30(4):711-9. PubMed ID: 19237604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans.
    Pfohl-Leszkowicz A; Manderville RA
    Mol Nutr Food Res; 2007 Jan; 51(1):61-99. PubMed ID: 17195275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats.
    Mally A; Pepe G; Ravoori S; Fiore M; Gupta RC; Dekant W; Mosesso P
    Chem Res Toxicol; 2005 Aug; 18(8):1253-61. PubMed ID: 16097798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ochratoxin A: lack of formation of covalent DNA adducts.
    Mally A; Zepnik H; Wanek P; Eder E; Dingley K; Ihmels H; Völkel W; Dekant W
    Chem Res Toxicol; 2004 Feb; 17(2):234-42. PubMed ID: 14967011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ochratoxin a and mitotic disruption: mode of action analysis of renal tumor formation by ochratoxin A.
    Mally A
    Toxicol Sci; 2012 Jun; 127(2):315-30. PubMed ID: 22403158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig.
    Faucet V; Pfohl-Leszkowicz A; Dai J; Castegnaro M; Manderville RA
    Chem Res Toxicol; 2004 Sep; 17(9):1289-96. PubMed ID: 15377164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis and oxidative stress induced by ochratoxin A in rat kidney.
    Petrik J; Zanić-Grubisić T; Barisić K; Pepeljnjak S; Radić B; Ferencić Z; Cepelak I
    Arch Toxicol; 2003 Dec; 77(12):685-93. PubMed ID: 13680094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ochratoxin A: apoptosis and aberrant exit from mitosis due to perturbation of microtubule dynamics?
    Rached E; Pfeiffer E; Dekant W; Mally A
    Toxicol Sci; 2006 Jul; 92(1):78-86. PubMed ID: 16641321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat.
    Marin-Kuan M; Nestler S; Verguet C; Bezençon C; Piguet D; Mansourian R; Holzwarth J; Grigorov M; Delatour T; Mantle P; Cavin C; Schilter B
    Toxicol Sci; 2006 Jan; 89(1):120-34. PubMed ID: 16251485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA adduct formation by ochratoxin A: review of the available evidence.
    Mally A; Dekant W
    Food Addit Contam; 2005; 22 Suppl 1():65-74. PubMed ID: 16332624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms.
    Marin-Kuan M; Cavin C; Delatour T; Schilter B
    Toxicon; 2008 Aug; 52(2):195-202. PubMed ID: 18649906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays.
    Luhe A; Hildebrand H; Bach U; Dingermann T; Ahr HJ
    Toxicol Sci; 2003 Jun; 73(2):315-28. PubMed ID: 12700408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships imply different mechanisms of action for ochratoxin A-mediated cytotoxicity and genotoxicity.
    Hadjeba-Medjdoub K; Tozlovanu M; Pfohl-Leszkowicz A; Frenette C; Paugh RJ; Manderville RA
    Chem Res Toxicol; 2012 Jan; 25(1):181-90. PubMed ID: 22126095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a new dechlorinated ochratoxin A derivative formed in opossum kidney cell cultures after pretreatment by modulators of glutathione pathways: correlation with DNA-adduct formation.
    Faucet-Marquis V; Pont F; Størmer FC; Rizk T; Castegnaro M; Pfohl-Leszkowicz A
    Mol Nutr Food Res; 2006 May; 50(6):530-42. PubMed ID: 16671059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on direct genotoxicity as a molecular mechanism of ochratoxin a carcinogenicity.
    Pfohl-Leszkowicz A; Manderville RA
    Chem Res Toxicol; 2012 Feb; 25(2):252-62. PubMed ID: 22054007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells.
    Kamp HG; Eisenbrand G; Schlatter J; Würth K; Janzowski C
    Toxicology; 2005 Jan; 206(3):413-25. PubMed ID: 15588931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation and nephrotoxicity of ochratoxin B in rats.
    Mally A; Keim-Heusler H; Amberg A; Kurz M; Zepnik H; Mantle P; Völkel W; Hard GC; Dekant W
    Toxicol Appl Pharmacol; 2005 Aug; 206(1):43-53. PubMed ID: 15963343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats.
    Mally A; Völkel W; Amberg A; Kurz M; Wanek P; Eder E; Hard G; Dekant W
    Chem Res Toxicol; 2005 Aug; 18(8):1242-52. PubMed ID: 16097797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of covalent adducts between DNA and ochratoxin a: a new factor in debate about genotoxicity and human risk assessment.
    Mantle PG; Faucet-Marquis V; Manderville RA; Squillaci B; Pfohl-Leszkowicz A
    Chem Res Toxicol; 2010 Jan; 23(1):89-98. PubMed ID: 19928877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.